{"id":2360,"date":"2022-02-22T00:00:00","date_gmt":"2022-02-22T05:00:00","guid":{"rendered":"https:\/\/mdbc2.wpenginepowered.com\/blog\/how-pharmacists-can-better-manage-take-home-cancer-drugs\/"},"modified":"2022-02-22T00:00:00","modified_gmt":"2022-02-22T05:00:00","slug":"how-pharmacists-can-better-manage-take-home-cancer-drugs","status":"publish","type":"blog","link":"https:\/\/www.mdbriefcase.com\/fr\/blog\/how-pharmacists-can-better-manage-take-home-cancer-drugs\/","title":{"rendered":"How Pharmacists Can Better Manage Take-Home Cancer Drugs"},"content":{"rendered":"

By: Carla Beaton, VP Quality Improvements & Innovations, Pharmapod<\/a> and Lisa Rambout, PhDHQ Queen\u2019s University<\/em><\/p>\n

An estimated two in five Canadians will get cancer<\/a> in their lifetime. The number of new cancer cases in Canada is expected to increase about 40 percent<\/a> in the next 15 years, resulting in more patients needing treatment, more treatments being offered, and more patients living longer with multiple chronic diseases.<\/p>\n

To help ease the strain on our healthcare system, take-home cancer drugs (THCD) are becoming the norm, with more than half of new cancer drugs now formulated to be taken orally or injected instead of infused in a hospital or private clinic setting.<\/p>\n

This new model \u2014 though convenient for patients \u2014 poses some potential safety risks.<\/p>\n

Previously, specialized hospital oncology pharmacists would screen medications administered in healthcare facilities for accuracy and safety \u2014 today, the majority of orders for THCD are sent directly to community pharmacies from prescribers, a shift that\u2019s caused some unease among pharmacists. Data shows 90 percent<\/a> of publicly funded THCD in Ontario are now dispensed from community pharmacies, yet less than 20 percent<\/a> of those pharmacists are comfortable with THCD.<\/p>\n

How can pharmacists adapt to this new normal while limiting the risk for THCD medication errors?<\/p>\n

PHARMACISTS AND HCPs: Learn more about how to reduce medication errors and improve patient safety. <\/strong>Register for our webinar, Mission Impossible: Can Reporting Medication Errors and Learning from Data be Easier?<\/strong><\/a><\/p>\n

Recommendations to Enhance Safety<\/strong><\/h2>\n

To improve pharmacist confidence and patient safety with take-home cancer drugs, Cancer Care Ontario recommends the following steps:<\/p>\n

Oncology Training<\/strong><\/h3>\n

Healthcare providers involved in prescribing, dispensing, patient education and\/or monitoring of take-home cancer drugs should have specific and standardized training in oncology care. It\u2019s also recommended that at least one oncology health professional \u2014 preferably a pharmacist with oncology training \u2014 verify the prescription following a set of standardized steps and document the verification was completed before it is sent to the dispensing pharmacy.<\/p>\n

Computerized Orders<\/strong><\/h3>\n

Computerized prescriber orders for intravenous cancer drugs have shown to save millions in healthcare costs by preventing hospitalizations, deaths, or adverse events. Equivalent standards for THCD should also be implemented.<\/p>\n

Clear Care Plan<\/strong><\/h3>\n

To facilitate an integrated care approach, a communication plan should be developed to ensure that patients and\/or caregivers and all members of the cancer care team across the treatment continuum have access to the same information. Numerous factors, including complex treatments, literacy, lack of understanding, and cognitive issues in patients can increase the risk of medication errors occurring that could cause harm. To prevent avoidable errors, pharmacists must be sure patients and\/or caregivers have a clear understanding of their care plan.<\/p>\n

Proper Guidance<\/strong><\/h3>\n

Pharmacists can use standardized tools, including the Multinational Association for Supportive Care in Cancer (MASCC) Oral Agent Teaching Tool<\/a> (MOATT) to access frameworks for effective patient education and communication strategies.<\/p>\n

Patients and\/or care providers should also be given clear guidance for proper medication storage, handling, disposal, side effects, potential interactions, and strategies for maintaining medication adherence.<\/p>\n

Closing the Care Gap<\/strong><\/h3>\n

Transitions in care and medication delivery always pose potential safety risks. For the THCD model to work \u2014 and for pharmacists to feel comfortable \u2014 it is imperative that acute care sites and community pharmacies communicate all patient safety events to each other.<\/p>\n

Incident management platforms such as Pharmapod<\/a> make it easy for pharmacy and healthcare professionals to report and track medication incidents and monitor trends and causes behind the errors to improve their practice over time.The intuitive cloud-based platform analyzes collected data and disseminates the learnings back to users, preventing the recurrence of patient harm. Book a custom demo today<\/a> to learn more.<\/strong><\/p>","protected":false},"excerpt":{"rendered":"

By: Carla Beaton, VP Quality Improvements & Innovations, Pharmapod and Lisa Rambout, PhDHQ Queen\u2019s University An estimated two in five Canadians will get cancer in their lifetime. The number of new cancer cases in Canada is expected to increase about 40 percent in the next 15 years, resulting in more patients needing treatment, more treatments […]<\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":false,"inline_featured_image":false},"categories":[68],"class_list":["post-2360","blog","type-blog","status-publish","hentry","category-live-virtual-events"],"acf":[],"yoast_head":"\nHow Pharmacists Can Better Manage Take-Home Cancer Drugs - MDBriefCase<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.mdbriefcase.com\/fr\/blog\/how-pharmacists-can-better-manage-take-home-cancer-drugs\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How Pharmacists Can Better Manage Take-Home Cancer Drugs - MDBriefCase\" \/>\n<meta property=\"og:description\" content=\"By: Carla Beaton, VP Quality Improvements & Innovations, Pharmapod and Lisa Rambout, PhDHQ Queen\u2019s University An estimated two in five Canadians will get cancer in their lifetime. The number of new cancer cases in Canada is expected to increase about 40 percent in the next 15 years, resulting in more patients needing treatment, more treatments […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.mdbriefcase.com\/fr\/blog\/how-pharmacists-can-better-manage-take-home-cancer-drugs\/\" \/>\n<meta property=\"og:site_name\" content=\"MDBriefCase\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/blog\\\/how-pharmacists-can-better-manage-take-home-cancer-drugs\\\/\",\"url\":\"https:\\\/\\\/www.mdbriefcase.com\\\/blog\\\/how-pharmacists-can-better-manage-take-home-cancer-drugs\\\/\",\"name\":\"How Pharmacists Can Better Manage Take-Home Cancer Drugs - MDBriefCase\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/#website\"},\"datePublished\":\"2022-02-22T05:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/blog\\\/how-pharmacists-can-better-manage-take-home-cancer-drugs\\\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.mdbriefcase.com\\\/blog\\\/how-pharmacists-can-better-manage-take-home-cancer-drugs\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/blog\\\/how-pharmacists-can-better-manage-take-home-cancer-drugs\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.mdbriefcase.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How Pharmacists Can Better Manage Take-Home Cancer Drugs\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/#website\",\"url\":\"https:\\\/\\\/www.mdbriefcase.com\\\/\",\"name\":\"MDBriefCase\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.mdbriefcase.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/#organization\",\"name\":\"MDBriefCase\",\"url\":\"https:\\\/\\\/www.mdbriefcase.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.mdbriefcase.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/logo.webp\",\"contentUrl\":\"https:\\\/\\\/www.mdbriefcase.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/logo.webp\",\"width\":190,\"height\":36,\"caption\":\"MDBriefCase\"},\"image\":{\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"How Pharmacists Can Better Manage Take-Home Cancer Drugs - MDBriefCase","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.mdbriefcase.com\/fr\/blog\/how-pharmacists-can-better-manage-take-home-cancer-drugs\/","og_locale":"fr_CA","og_type":"article","og_title":"How Pharmacists Can Better Manage Take-Home Cancer Drugs - MDBriefCase","og_description":"By: Carla Beaton, VP Quality Improvements & Innovations, Pharmapod and Lisa Rambout, PhDHQ Queen\u2019s University An estimated two in five Canadians will get cancer in their lifetime. The number of new cancer cases in Canada is expected to increase about 40 percent in the next 15 years, resulting in more patients needing treatment, more treatments […]","og_url":"https:\/\/www.mdbriefcase.com\/fr\/blog\/how-pharmacists-can-better-manage-take-home-cancer-drugs\/","og_site_name":"MDBriefCase","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.mdbriefcase.com\/blog\/how-pharmacists-can-better-manage-take-home-cancer-drugs\/","url":"https:\/\/www.mdbriefcase.com\/blog\/how-pharmacists-can-better-manage-take-home-cancer-drugs\/","name":"How Pharmacists Can Better Manage Take-Home Cancer Drugs - MDBriefCase","isPartOf":{"@id":"https:\/\/www.mdbriefcase.com\/#website"},"datePublished":"2022-02-22T05:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.mdbriefcase.com\/blog\/how-pharmacists-can-better-manage-take-home-cancer-drugs\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.mdbriefcase.com\/blog\/how-pharmacists-can-better-manage-take-home-cancer-drugs\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.mdbriefcase.com\/blog\/how-pharmacists-can-better-manage-take-home-cancer-drugs\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.mdbriefcase.com\/"},{"@type":"ListItem","position":2,"name":"How Pharmacists Can Better Manage Take-Home Cancer Drugs"}]},{"@type":"WebSite","@id":"https:\/\/www.mdbriefcase.com\/#website","url":"https:\/\/www.mdbriefcase.com\/","name":"MDBriefCase","description":"","publisher":{"@id":"https:\/\/www.mdbriefcase.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.mdbriefcase.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.mdbriefcase.com\/#organization","name":"MDBriefCase","url":"https:\/\/www.mdbriefcase.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","contentUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","width":190,"height":36,"caption":"MDBriefCase"},"image":{"@id":"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/blog\/2360","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/blog"}],"about":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/types\/blog"}],"wp:attachment":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/media?parent=2360"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/categories?post=2360"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}